Clinical Trial Update: A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of ranibizumab 0.5 mg in diabetic patients with visual impairment due to macular edema. The study status is COM…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Visual Impairment, Macular Edema | Phase 4 | Status: COMPLETED